{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:48:52Z","timestamp":1790844532400,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH NCATS","award":["1R21TR001718-01"],"award-info":[{"award-number":["1R21TR001718-01"]}]},{"name":"NIH NCATS","award":["1UH2TR002084-01"],"award-info":[{"award-number":["1UH2TR002084-01"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1U01CA207160"],"award-info":[{"award-number":["1U01CA207160"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Russian Government Program of Competitive Growth of Kazan Federal University"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.drudis.2018.01.018","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T15:27:34Z","timestamp":1515511654000},"page":"661-672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":193,"title":["A bibliometric review of drug repurposing"],"prefix":"10.1016","volume":"23","author":[{"given":"Nancy C.","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Ekins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tropsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2018.01.018_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drudis.2017.08.008","article-title":"Finding hidden treasures in old drugs: the challenges and importance of licensing generics","volume":"23","author":"Simsek","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2018.01.018_bib0010","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drudis.2018.01.018_bib0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/bib\/bbr005","article-title":"Literature mining, ontologies and information visualization for drug repurposing","volume":"12","author":"Andronis","year":"2011","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.drudis.2018.01.018_bib0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/bib\/bbr013","article-title":"Exploiting drug\u2013disease relationships for computational drug repositioning","volume":"12","author":"Dudley","year":"2011","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.drudis.2018.01.018_bib0025","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.drudis.2011.02.016","article-title":"In silico repositioning of approved drugs for rare and neglected diseases","volume":"16","author":"Ekins","year":"2011","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2018.01.018_bib0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/bib\/bbr021","article-title":"Drug repositioning for orphan diseases","volume":"12","author":"Sardana","year":"2011","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.drudis.2018.01.018_bib0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3332\/ecancer.2014.485","article-title":"The Repurposing Drugs in Oncology (ReDO) Project","volume":"8","author":"Pantziarka","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.drudis.2018.01.018_bib0040","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2174\/1389450115666140714121514","article-title":"New use for old drugs? Prospective targets of chloroquines in cancer therapy","volume":"15","author":"Vlahopoulos","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.drudis.2018.01.018_bib0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2217\/fon.14.244","article-title":"Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy?","volume":"11","author":"Pantziarka","year":"2015","journal-title":"Future Oncol."},{"key":"10.1016\/j.drudis.2018.01.018_bib0050","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/j.bmcl.2016.03.103","article-title":"Repurposing strategies for tropical disease drug discovery","volume":"26","author":"Klug","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2018.01.018_bib0055","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jbi.2010.03.008","article-title":"Mining connections between chemicals, proteins, and diseases extracted from Medline annotations","volume":"43","author":"Baker","year":"2010","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.drudis.2018.01.018_bib0060","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrd2030","article-title":"Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond","volume":"5","author":"Ghofrani","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drudis.2018.01.018_bib0065","unstructured":"[No authors listed] (2006) Inflammation: a unifying theory of disease? Research is showing that chronic inflammation may be the common factor in many diseases. Harv. Health Lett. 31, 4\u20135"},{"key":"10.1016\/j.drudis.2018.01.018_bib0070","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/embor.2012.142","article-title":"The inflammation theory of disease. The growing realization that chronic inflammation is crucial in many diseases opens new avenues for treatment","volume":"13","author":"Hunter","year":"2012","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drudis.2018.01.018_bib0075","first-page":"593","article-title":"Urinary steroids in pemphigus patients treated with cortisone, prednisone and prednisolone","volume":"6","author":"Bruni","year":"1955","journal-title":"Soc. Ital. Dermatol. Sifilogr. Sezioni. Interprov."},{"key":"10.1016\/j.drudis.2018.01.018_bib0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.anl.2014.11.002","article-title":"Steroid-dependent sensorineural hearing loss in a patient with Charcot-Marie-Tooth disease showing auditory neuropathy","volume":"42","author":"Maeda","year":"2015","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.drudis.2018.01.018_bib0085","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.sleep.2009.11.010","article-title":"Oral glucocorticosteroids: effective in a case of restless legs syndrome resistant to other therapies","volume":"11","author":"Oscroft","year":"2010","journal-title":"Sleep Med."},{"key":"10.1016\/j.drudis.2018.01.018_bib0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10401230591002002","article-title":"History of the discovery and clinical introduction of chlorpromazine","volume":"17","author":"Lopez-Munoz","year":"2005","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.drudis.2018.01.018_bib0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10673220802432350","article-title":"Neurosyphilis, malaria, and the discovery of antipsychotic agents","volume":"16","author":"Frankenburg","year":"2008","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.drudis.2018.01.018_bib0100","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(55)92850-6","article-title":"Chlorpromazine in the management of tetanus","volume":"269","author":"Cole","year":"1955","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2018.01.018_bib0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.1955.02950210005002","article-title":"Chlorpromazine (thorazine) in the treatment of intractable hiccups","volume":"157","author":"Friedgood","year":"1955","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.drudis.2018.01.018_bib0110","first-page":"23","article-title":"The use of chlorpromazine as an adjunct in the treatment of psychomotor epilepsy: a preliminary report","volume":"15","author":"Head","year":"1955","journal-title":"Bull. Tulane Univ. Med. Fac."},{"key":"10.1016\/j.drudis.2018.01.018_bib0115","first-page":"15","article-title":"Thorazine-Phenergan in the treatment of preeclampsia","volume":"41","author":"Fernandes","year":"1956","journal-title":"An. Bras. Ginecol."},{"key":"10.1016\/j.drudis.2018.01.018_bib0120","first-page":"1","article-title":"Chlorpromazine in normal labor","volume":"8","author":"Harer","year":"1956","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.drudis.2018.01.018_bib0125","first-page":"482","article-title":"Treatment of minor chorea with chlorpromazine","volume":"41","author":"Fortes","year":"1957","journal-title":"Port. Med."},{"key":"10.1016\/j.drudis.2018.01.018_bib0130","first-page":"420","article-title":"The use of chlorpromazine in intractable pain associated with terminal carcinoma","volume":"75","author":"Campbell","year":"1956","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.drudis.2018.01.018_bib0135","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(72)92955-8","article-title":"Chlorpromazines and cancer","volume":"2","author":"Csatary","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2018.01.018_bib0140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.125.3241.233","article-title":"Effect of reserpine and chlorpromazine on sarcoma 37","volume":"125","author":"Belkin","year":"1957","journal-title":"Science"},{"key":"10.1016\/j.drudis.2018.01.018_bib0145","first-page":"897","article-title":"Effects of some tranquilizers on a mammary adenocarcinoma in mice","volume":"18","author":"Cranston","year":"1958","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2018.01.018_bib0150","first-page":"1912","article-title":"Antineoplastic effect of chlorpromazine in chemical carcinogenesis in the hamster cheek pouch","volume":"32","author":"Polliack","year":"1972","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2018.01.018_bib0155","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/CAD.0b013e32832ec041","article-title":"The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells","volume":"20","author":"Yde","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.drudis.2018.01.018_bib0160","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0006-2952(01)00840-1","article-title":"Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin","volume":"63","author":"Kalkanidis","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drudis.2018.01.018_bib0165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/AAC.36.1.209","article-title":"In vitro activities of chloroquine in combination with chlorpromazine or prochlorperazine against isolates of Plasmodium falciparum","volume":"36","author":"Basco","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2018.01.018_bib0170","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2044.1954.tb01927.x","article-title":"Chlorpromazine and the production of hypothermia","volume":"9","author":"Dundee","year":"1954","journal-title":"Anaesthesia"},{"key":"10.1016\/j.drudis.2018.01.018_bib0175","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1179\/1743132815Y.0000000031","article-title":"Enhanced beneficial effects of mild hypothermia by phenothiazine drugs in stroke therapy","volume":"37","author":"Liu","year":"2015","journal-title":"Neurol. Res."},{"key":"10.1016\/j.drudis.2018.01.018_bib0180","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/cmdc.200600240","article-title":"Malaria chemotherapeutics part I: history of antimalarial drug development, currently used therapeutics, and drugs in clinical development","volume":"2","author":"Schlitzer","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.drudis.2018.01.018_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-012-2886-x","article-title":"From methylene blue to chloroquine: a brief review of the development of an antimalarial therapy","volume":"111","author":"Krafts","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.drudis.2018.01.018_bib0190","doi-asserted-by":"crossref","unstructured":"[No authors listed] (1946) ACTIVITY of a new antimalarial agent, chloroquine (SN 7618). J. Am. Med. Assoc. 130, 1069.","DOI":"10.1001\/jama.1946.02870160015006"},{"key":"10.1016\/j.drudis.2018.01.018_bib0195","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/art.1780130310","article-title":"An appraisal of chloroquine","volume":"13","author":"Mackenzie","year":"1970","journal-title":"Arthritis Rheum."},{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2018.01.018_bib0200","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/0961203396005001021","article-title":"The history of antimalarials","volume":"5","author":"Wallace","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.drudis.2018.01.018_bib0205","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(51)91643-1","article-title":"Treatment of lupus erythematosus with mepacrine","volume":"2","author":"Page","year":"1951","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2018.01.018_bib0210","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/jama.1953.63690150002009a","article-title":"Chloroquine diphosphate in treatment of discoid lupus erythematosus","volume":"152","author":"Goldman","year":"1953","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.drudis.2018.01.018_bib0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00000441-195322510-00012","article-title":"Rheumatoid arthritis therapy: a rationale and the use of chloroquine diphosphate","volume":"225","author":"Haydu","year":"1953","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.drudis.2018.01.018_bib0220","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00436-009-1524-8","article-title":"Seventy-five years of Resochin in the fight against malaria","volume":"105","author":"Jensen","year":"2009","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.drudis.2018.01.018_bib0225","first-page":"305","article-title":"Chloroquine: novel uses & manifestations","volume":"127","author":"Cooper","year":"2008","journal-title":"Indian J. Med. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2018.01.018_bib0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0961203396005001031","article-title":"Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development","volume":"5","author":"Fox","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.drudis.2018.01.018_bib0235","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejphar.2009.06.063","article-title":"Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies","volume":"625","author":"Solomon","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drudis.2018.01.018_bib0240","first-page":"230","article-title":"Vascular protection by chloroquine during brain tumor therapy with Tf-CRM107","volume":"60","author":"Hagihara","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2018.01.018_bib0245","doi-asserted-by":"crossref","first-page":"e838","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drudis.2018.01.018_bib0250","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1073\/pnas.1515617113","article-title":"Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy","volume":"113","author":"Eng","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2018.01.018_bib0255","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mehy.2013.04.009","article-title":"Metabolic stress in infected cells may represent a therapeutic target for human immunodeficiency virus infection","volume":"81","author":"Alonso-Villaverde","year":"2013","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.drudis.2018.01.018_bib0260","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.micinf.2015.05.006","article-title":"Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent","volume":"17","author":"Chauhan","year":"2015","journal-title":"Microbes Infect."},{"key":"10.1016\/j.drudis.2018.01.018_bib0265","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12977-015-0178-0","article-title":"Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV\/AIDS","volume":"12","author":"Savarino","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/j.drudis.2018.01.018_bib0270","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/toxins7030659","article-title":"Biology, genetics, and management of ergot (Claviceps spp.) in rye, sorghum, and pearl millet","volume":"7","author":"Miedaner","year":"2015","journal-title":"Toxins"},{"key":"10.1016\/j.drudis.2018.01.018_bib0275","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0028-2243(95)02104-Z","article-title":"History of ergot alkaloids from ergotism to ergometrine","volume":"60","author":"van Dongen","year":"1995","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.drudis.2018.01.018_bib0280","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jocn.2003.05.002","article-title":"Ergot of rye-the first specific for migraine","volume":"11","author":"Eadie","year":"2004","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.drudis.2018.01.018_bib0285","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1129-2377-16-5","article-title":"Therapeutic effect of intranasal evaporative cooling in patients with migraine: a pilot study","volume":"16","author":"Vanderpol","year":"2015","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.drudis.2018.01.018_bib0290","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s10194-015-0539-z","article-title":"Two TRPV1 receptor antagonists are effective in two different experimental models of migraine","volume":"16","author":"Meents","year":"2015","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.drudis.2018.01.018_bib0295","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1358\/mf.2010.32.8.1507853","article-title":"A novel TRPV1 receptor antagonist JNJ-17203212 attenuates colonic hypersensitivity in rats","volume":"32","author":"Wiskur","year":"2010","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.drudis.2018.01.018_bib0300","unstructured":"Repurposing Drugs (2017) Available at: https:\/\/ncats.nih.gov\/preclinical\/repurpose"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644617302878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644617302878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:36:28Z","timestamp":1761222988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644617302878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1359644617302878"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2018.01.018","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A bibliometric review of drug repurposing","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2018.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}